Evaluation of a combination of off-label PDE5 inhibitor and tamoxifen in acute Peyronie's disease. - Shah M; Megson M; Al-Mitwalli A; Fratangelo R; Shergill P; Shahzad R; Di Giovanni A; Zhang J; Lee WG; Ralph DJ; Cellek S (The journal of sexual medicine, 2026)